129 related articles for article (PubMed ID: 12816901)
1. DNA integrity as a potential marker for stool-based detection of colorectal cancer.
Boynton KA; Summerhayes IC; Ahlquist DA; Shuber AP
Clin Chem; 2003 Jul; 49(7):1058-65. PubMed ID: 12816901
[TBL] [Abstract][Full Text] [Related]
2. A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening.
Zou H; Harrington J; Rego RL; Ahlquist DA
Clin Chem; 2007 Sep; 53(9):1646-51. PubMed ID: 17712002
[TBL] [Abstract][Full Text] [Related]
3. Pilot study of the sensitivity and specificity of the DNA integrity assay for stool-based detection of colorectal cancer in Malaysian patients.
Yehya AH; Yusoff NM; Khalid IA; Mahsin H; Razali RA; Azlina F; Mohammed KS; Ali SA
Asian Pac J Cancer Prev; 2012; 13(5):1869-72. PubMed ID: 22901138
[TBL] [Abstract][Full Text] [Related]
4. A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening.
Zou H; Harrington JJ; Klatt KK; Ahlquist DA
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1115-9. PubMed ID: 16775168
[TBL] [Abstract][Full Text] [Related]
5. Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.
Dollinger MM; Behl S; Fleig WE
Clin Lab; 2018 Oct; 64(10):1719-1730. PubMed ID: 30336540
[TBL] [Abstract][Full Text] [Related]
6. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
Huang Z; Li L; Wang J
Dig Dis Sci; 2007 Sep; 52(9):2287-91. PubMed ID: 17410438
[TBL] [Abstract][Full Text] [Related]
8. Stool DNA Integrity Method for Colorectal Cancer Detection.
Rengucci C; De Maio G; Menghi M; Calistri D
Methods Mol Biol; 2018; 1765():193-202. PubMed ID: 29589309
[TBL] [Abstract][Full Text] [Related]
9. HUMAN DNA QUANTIFICATION IN THE STOOLS OF PATIENTS WITH COLORECTAL CANCER.
Teixeira Y; Lima JM; Souza ML; Aguiar P; Silva TD; Forones NM
Arq Gastroenterol; 2015 Dec; 52(4):293-8. PubMed ID: 26840470
[TBL] [Abstract][Full Text] [Related]
10. SFRP2 methylation in fecal DNA--a marker for colorectal polyps.
Oberwalder M; Zitt M; Wöntner C; Fiegl H; Goebel G; Zitt M; Köhle O; Mühlmann G; Ofner D; Margreiter R; Müller HM
Int J Colorectal Dis; 2008 Jan; 23(1):15-9. PubMed ID: 17639423
[TBL] [Abstract][Full Text] [Related]
11. Improved fecal DNA test for colorectal cancer screening.
Itzkowitz SH; Jandorf L; Brand R; Rabeneck L; Schroy PC; Sontag S; Johnson D; Skoletsky J; Durkee K; Markowitz S; Shuber A
Clin Gastroenterol Hepatol; 2007 Jan; 5(1):111-7. PubMed ID: 17161655
[TBL] [Abstract][Full Text] [Related]
12. Mutant-enriched PCR and allele-specific hybridization reaction to detect K-ras mutations in stool DNA: high prevalence in a large sample of older adults.
Haug U; Hillebrand T; Bendzko P; Löw M; Rothenbacher D; Stegmaier C; Brenner H
Clin Chem; 2007 Apr; 53(4):787-90. PubMed ID: 17317884
[TBL] [Abstract][Full Text] [Related]
13. Detecting colorectal cancer in stool with the use of multiple genetic targets.
Dong SM; Traverso G; Johnson C; Geng L; Favis R; Boynton K; Hibi K; Goodman SN; D'Allessio M; Paty P; Hamilton SR; Sidransky D; Barany F; Levin B; Shuber A; Kinzler KW; Vogelstein B; Jen J
J Natl Cancer Inst; 2001 Jun; 93(11):858-65. PubMed ID: 11390535
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
[TBL] [Abstract][Full Text] [Related]
15. Detection of
Olmedillas-López S; Lévano-Linares DC; Alexandre CLA; Vega-Clemente L; Sánchez EL; Villagrasa A; Ruíz-Tovar J; García-Arranz M; García-Olmo D
World J Gastroenterol; 2017 Oct; 23(39):7087-7097. PubMed ID: 29093617
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review.
Rasmussen SL; Krarup HB; Sunesen KG; Pedersen IS; Madsen PH; Thorlacius-Ussing O
Colorectal Dis; 2016 Jun; 18(6):549-61. PubMed ID: 26998585
[TBL] [Abstract][Full Text] [Related]
17. Quantification and integrity analysis of DNA in the stool of colorectal cancer patients may represent a complex alternative to fecal occult blood testing.
de Kok JB
Clin Chem; 2003 Dec; 49(12):2112-3. PubMed ID: 14633900
[No Abstract] [Full Text] [Related]
18. Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis.
Iannone A; Losurdo G; Pricci M; Girardi B; Massaro A; Principi M; Barone M; Ierardi E; Di Leo A
J Gastrointest Cancer; 2016 Jun; 47(2):143-51. PubMed ID: 26922358
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection.
Rengucci C; De Maio G; Menghi M; Benzi F; Calistri D
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32568232
[TBL] [Abstract][Full Text] [Related]
20. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.
Slaby O
Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
